Search Results

CID-1067700 10mg  | 95%

APEXBIO TECHNOLOGY LLC

competitive inhibitor of nucleotide binding by Ras-related GTPases Cancer Biology|Ras-like GTPases

More Information Supplier Page

×

CID-1067700

CID-1067700 5mg  | 95%

APEXBIO TECHNOLOGY LLC

competitive inhibitor of nucleotide binding by Ras-related GTPases Cancer Biology|Ras-like GTPases

More Information Supplier Page

×

CID-1067700

ML-243 25mg  | 98%

APEXBIO TECHNOLOGY LLC

inhibitor of cancer stem cells Stem Cell|Cancer stem cell

More Information Supplier Page

×

ML-243

ML-243 10mg  | 98%

APEXBIO TECHNOLOGY LLC

inhibitor of cancer stem cells Stem Cell|Cancer stem cell

More Information Supplier Page

×

ML-243

ML-243 5mg  | 98%

APEXBIO TECHNOLOGY LLC

inhibitor of cancer stem cells Stem Cell|Cancer stem cell

More Information Supplier Page

×

ML-243

ML-098 25mg  | 99.72%

APEXBIO TECHNOLOGY LLC

activator of the GTP-binding protein Rab7 Cancer Biology|Ras-like GTPases

More Information Supplier Page

×

ML-098

Lorglumide (sodium salt) 25mg  | 98%

APEXBIO TECHNOLOGY LLC

nonpeptidic antagonist of the CCK A receptor GPCR/G protein|CCK1 Receptors

More Information Supplier Page

×

Lorglumide (sodium salt)

Lorglumide (sodium salt) 50mg  | 98%

APEXBIO TECHNOLOGY LLC

nonpeptidic antagonist of the CCK A receptor GPCR/G protein|CCK1 Receptors

More Information Supplier Page

×

Lorglumide (sodium salt)

N-tert-butyl-α-Phenylnitrone 500mg  | 98%

APEXBIO TECHNOLOGY LLC

COX-2 inhibitor Neuroscience|COX

More Information Supplier Page

×

N-tert-butyl-α-Phenylnitrone

N-tert-butyl-α-Phenylnitrone 1g  | 98%

APEXBIO TECHNOLOGY LLC

COX-2 inhibitor Neuroscience|COX

More Information Supplier Page

×

N-tert-butyl-α-Phenylnitrone